TCM

Tang Capital Management Portfolio holdings

AUM $1.81B

This Quarter Return

-5.03%

1 Year Return

-0.32%

3 Year Return

+265.66%

5 Year Return

+421.21%

10 Year Return

+1,438.57%

AUM

$1.81B

AUM Growth

+$296M (+20%)

Cap. Flow

+$415M

Cap. Flow % of AUM

22.93%

Top 10 Holdings %Top 10 Hldgs %

39.2%

Holding

208

New

Increased

Reduced

Closed

Top Buys

1	Dynavax Technologies DVAX	$50.6M
2	Galapagos GLPG	$45.2M
3	Kiniksa Pharmaceuticals KNSA	$33.1M
4	Spyre Therapeutics SYRE	$33.1M
5	SLRN ACELYRIN SLRN	$24.3M

Top Sells

1	ITCI Intra-Cellular Therapies Inc. ITCI	$10.6M
2	OMIC Singular Genomics Systems, Inc. Common Stock OMIC	$7.23M
3	GRAL GRAIL, Inc. Common Stock GRAL	$4.82M
4	ALMS Alumis Inc. Common Stock ALMS	$4.72M
5	KLRS Kalaris Therapeutics, Inc. Common Stock KLRS	$1.95M

Sector Composition

1	Healthcare	94.79%
2	Technology	1.25%
3	Communication Services	1.23%
4	Consumer Discretionary	0.99%
5	Financials	0.57%

#	Name	Market Value	Portfolio Weight	Shares or Principal	Shares Change %	Capital Flow
51	51 Moderna MRNA $12.1B	$8.66M	0.48%	305,300 +5,300	+2%	+$150K
52	52 Cullinan Oncology CGEM $444M	$8.49M	0.47%	1,121,138 +200,000	+22%	+$1.51M
53	53 Elanco Animal Health ELAN $7.34B	$8.4M	0.46%	800,100 +100	+0%	+$1.05K
54	54 Pliant Therapeutics PLRX $87.8M	$8.1M	0.45%	+6,000,000	New	+$8.1M
55	55 Bausch + Lomb BLCO $4.91B	$7.98M	0.44%	550,000 +100,000	+22%	+$1.45M
56	56 Insmed INSM $19.5B	$7.63M	0.42%	100,000	–	–
57	57 Phathom Pharmaceuticals PHAT $555M	$7.52M	0.42%	1,200,000 +700,000	+140%	+$4.39M
58	58 Apogee Therapeutics APGE $2.29B	$7.47M	0.41%	200,000 +100,000	+100%	+$3.74M
59	59 HilleVax HLVX $103M	$7.13M	0.39%	4,920,000	–	–
60	60 ImmunityBio IBRX $2.43B	$7.02M	0.39%	2,333,333 -480,859	-17%	-$1.45M
61	61 Nuvation Bio NUVB $783M	$6.86M	0.38%	3,900,000	–	–
62	62 ESSA Pharma EPIX $83.4M	$6.79M	0.38%	4,300,000	–	–
63	63 Edgewise Therapeutics EWTX $1.42B	$6.6M	0.37%	300,000	–	–
64	64 Viking Therapeutics VKTX $3.6B	$6.52M	0.36%	270,000 -50,000	-16%	-$1.21M
65	65 Design Therapeutics DSGN $226M	$6.49M	0.36%	1,680,975 +200,000	+14%	+$772K
66	66 Regeneron Pharmaceuticals REGN $58.6B	$6.34M	0.35%	10,000 +8,000	+400%	+$5.07M
67	67 Adicet Bio ACET $62.8M	$6.21M	0.34%	8,223,612 +77,624	+1%	+$58.6K
68	BIOA 68 BioAge Labs, Inc. Common Stock BIOA $166M	$6.02M	0.33%	1,600,000 +281,639	+21%	+$1.06M
69	69 BioCryst Pharmaceuticals BCRX $1.8B	$6M	0.33%	800,000	–	–
70	70 Iovance Biotherapeutics IOVA $745M	$5.99M	0.33%	1,800,000 +1,300,000	+260%	+$4.33M
71	71 AbCellera Biologics ABCL $1.34B	$5.8M	0.32%	2,600,000 +17,184	+0.7%	+$38.3K
72	72 Rocket Pharmaceuticals RCKT $328M	$5.67M	0.31%	850,000 +100,000	+13%	+$667K
73	73 Heron Therapeutics HRTX $294M	$4.92M	0.27%	2,235,459 +95,188	+4%	+$209K
74	74 Lantheus LNTH $4.86B	$4.88M	0.27%	50,000	–	–
75	75 Dianthus Therapeutics DNTH $656M	$4.8M	0.27%	264,692	–	–